Correlation Between GlaxoSmithKline PLC and Evolve Artificial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Evolve Artificial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Evolve Artificial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Evolve Artificial Intelligence, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Evolve Artificial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Evolve Artificial. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Evolve Artificial.

Diversification Opportunities for GlaxoSmithKline PLC and Evolve Artificial

-0.88
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Evolve is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Evolve Artificial Intelligence in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evolve Artificial and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Evolve Artificial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evolve Artificial has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Evolve Artificial go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Evolve Artificial

Considering the 90-day investment horizon GlaxoSmithKline PLC is expected to generate 19.53 times less return on investment than Evolve Artificial. But when comparing it to its historical volatility, GlaxoSmithKline PLC ADR is 1.55 times less risky than Evolve Artificial. It trades about 0.01 of its potential returns per unit of risk. Evolve Artificial Intelligence is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  516.00  in Evolve Artificial Intelligence on August 29, 2024 and sell it today you would earn a total of  612.00  from holding Evolve Artificial Intelligence or generate 118.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Evolve Artificial Intelligence

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Evolve Artificial 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Evolve Artificial Intelligence are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of very weak basic indicators, Evolve Artificial may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Evolve Artificial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Evolve Artificial

The main advantage of trading using opposite GlaxoSmithKline PLC and Evolve Artificial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Evolve Artificial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolve Artificial will offset losses from the drop in Evolve Artificial's long position.
The idea behind GlaxoSmithKline PLC ADR and Evolve Artificial Intelligence pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios